Abstract: Embodiments disclosed herein are directed to a stabilization feature configured to be coupled to an ultrasound probe, or similar medical device and grasped by one or more fingers of a user. The user can then manipulate the stabilization feature and probe assembly without requiring any opposing pressure to be applied by the thumb. As such a user is free to use the thumb to operate controls disposed on the probe, or stabilize a skin surface, or the like. The stabilization feature can include a first portion configured to be grasped by one or more fingers, and a second portion configured to engage the probe. Further, the second portion can engage the probe through a sheath to maintain a sterile barrier therebetween. Alternatively, the first portion can be grasped by one or more fingers through a sheath to maintain a sterile barrier therebetween.

Abstract: Disclosed herein are ultrasound probe assemblies that include the probe, a sheath, and an accessory implement that may be selectively attached to and detached form the probe. The implement includes an attachment surface for attaching accessories thereto. The attachment surface includes a defined angle with respect to the head of the probe so that accessories attached thereto are disposed in a defined alignment with the probe. The implement includes a circumferential wall defining a cavity configure to receive the probe head therein. The cavity includes a bottom opening to expose a patient coupling surface of the probe. The assembly may include an ultrasound gel disposed within the opening. The sheath may include a stretchable band to secure the sheath to the probe. The sheath defines a sterile barrier and may be attached to the implement.

Abstract: Disclosed herein is a system, apparatus and method directed to a magnetizer comprising at least one magnet; and a housing, the housing comprising: a top face; a bottom face positioned on an opposite side of the housing from the top face; a plurality of faces adjoining the top face and the bottom face; an interior comprising an interior surface formed at least in part by the top face, the bottom face and the plurality of faces; wherein the top face includes a first opening configured to receive a medical device; and wherein the at least one magnet is positioned within the interior of the housing. A face of the plurality of faces may include a second opening to expose at least a portion of the interior surface through the second opening. The second opening may be larger than the first opening.

Abstract: Contamination detection systems, kits, and techniques are described for testing surfaces for the presence of hazardous contaminants, while minimizing user exposure to these contaminants. Even trace amounts of contaminants can be detected. A collection kit provides a swab that is simple to use, easy to hold and grip, allows the user to swab large areas of a surface, and keeps the user's hands away from the surface being tested. The kit also provides open and closed fluid transfer mechanism to transfer the collected fluid to a detection device while minimizing user exposure to hazardous contaminants in the collected fluid. Contamination detection kits can rapidly collect and detect hazardous drugs, including trace amounts of antineoplastic agents, in healthcare settings at the site of contamination.

Abstract: Contamination detection systems, kits, and techniques are described for testing surfaces for the presence of hazardous contaminants, while minimizing user exposure to these contaminants. Even trace amounts of contaminants can be detected. A collection kit provides a swab that is simple to use, easy to hold and grip, allows the user to swab large areas of a surface, and keeps the user's hands away from the surface being tested. The kit also provides open and closed fluid transfer mechanism to transfer the collected fluid to a detection device while minimizing user exposure to hazardous contaminants in the collected fluid. Contamination detection kits can rapidly collect and detect hazardous drugs, including trace amounts of antineoplastic agents, in healthcare settings at the site of contamination.

Abstract: A medication filling device and system are provided. The filling device is configured to attach to a medication delivery device and includes a vial attachment component configured to attach to a medication vial. The vial attachment component includes a pump, operable in forward and reverse directions, and an empty vial detection unit configured to detect whether a vial attached to the vial attachment component is empty. The filling device further includes a processor configured to receive a signal from the empty vial detection unit indicating whether a vial attached to the vial attachment component is empty, and a user interface configured to output an indication to a user indicating whether the vial is empty.

Abstract: An ultrasound probe is disclosed including a body (102), a lens included on head portion (44) of the body, a stabilizing portion (146) extending from the body and configured to stabilize the body on a skin surface of a patient without user assistance, and a finger-grip portion (110) configured to enable a user of the ultrasound probe to grasp and maneuver the ultrasound probe during use thereof with no more than two or three fingers on a single hand of the user. The ultrasound probe may further include a cable conduit (194) and a cable boot (195) configured to house a distal-end portion of a power-and-data cable and to keep the cable away from the head portion. The stabilizing portion may include a latitudinal channel (147) that reduces a surface area of the stabilizing portion intended to face the skin surface of the patient, in order to facilitate movement of the ultrasound probe across the skin surface and to reduce suction hen gel is present and the ultrasound probe is removed from the patient.

Abstract: Contamination detection systems, kits, and techniques are described for testing surfaces for the presence of hazardous contaminants, while minimizing user exposure to these contaminants. Even trace amounts of contaminants can be detected. A collection kit provides a swab that is simple to use, easy to hold and grip, allows the user to swab large areas of a surface, and keeps the user's hands away from the surface being tested. The kit also provides open and closed fluid transfer mechanism to transfer the collected fluid to a detection device while minimizing user exposure to hazardous contaminants in the collected fluid. Contamination detection kits can rapidly collect and detect hazardous drugs, including trace amounts of antineoplastic agents, in healthcare settings at the site of contamination.

Abstract: Embodiments disclosed herein are directed to a stabilization feature configured to be coupled to an ultrasound probe, or similar medical device and grasped by one or more fingers of a user. The user can then manipulate the stabilization feature and probe assembly without requiring any opposing pressure to be applied by the thumb. As such a user is free to use the thumb to operate controls disposed on the probe, or stabilize a skin surface, or the like. The stabilization feature can include a first portion configured to be grasped by one or more fingers, and a second portion configured to engage the probe. Further, the second portion can engage the probe through a sheath to maintain a sterile barrier therebetween. Alternatively, the first portion can be grasped by one or more fingers through a sheath to maintain a sterile barrier therebetween.

Abstract: A medicament filling system (30) provides medicament to a delivery device (20). The medicament filling system (30) comprises a main housing (40) having an air pump (42), a vial adapter (44) that is configured to engage a vial (10) containing medicament, the vial adapter (44) being in communication with the air pump (42), a syringe housing (46) that carries a syringe (70), the syringe housing (46) being in selective communication with the vial adapter (44) and the delivery device (20), and a valve (60) that locks and unlocks movement of a plunger (72) in the syringe (70).

Abstract: A syringe assembly (2) that locks a syringe (10) to prevent backflow of medicament, the syringe assembly (2) comprising a syringe (10) including a barrel (12) configured to carry the medicament, a plunger (14) that communicates with the barrel (12), and a plunger head (16) disposed on a proximal end of the plunger (14), and a locking assembly (50) disposed around the barrel (12), wherein the locking assembly (50) prevents the plunger (14) from moving away from the barrel (12) to draw the medicament into the barrel (12).

Abstract: Embodiments disclosed herein are directed to a vessel assessment system configured to image a target vessel and determine which vascular access device (VAD) to use to access the target vessel while remaining within one or more insertion parameters of percentage vessel occupancy, and dwell length given a predetermined range of insertion angles. The system can superimpose a target vessel sizing ring to measure a diameter or cross-sectional area, or to measure a depth of the target vessel. Further, the system can provide a list of VAD's that can access the target vessel within one or more insertion parameters. The system can provide an icon representing the VAD superimposed over the target vessel to provide a visual representation of the vascular access device within the target vessel.

Abstract: Aspects of the disclosure relate to augmented reality devices for generating a composite scene including a real-world test environment and an augmented reality overlay visually representing a test area of the environment. Some devices can include wearable displays for displaying an overlay to a user, and other devices can include projectors for illuminating the test environment with the overlay.

Abstract: Disclosed herein is a system, apparatus and method directed to a magnetizer comprising at least one magnet; and a housing, the housing comprising: a top face; a bottom face positioned on an opposite side of the housing from the top face; a plurality of faces adjoining the top face and the bottom face; an interior comprising an interior surface formed at least in part by the top face, the bottom face and the plurality of faces; wherein the top face includes a first opening configured to receive a medical device; and wherein the at least one magnet is positioned within the interior of the housing. A face of the plurality of faces may include a second opening to expose at least a portion of the interior surface through the second opening. The second opening may be larger than the first opening.

Abstract: Contamination detection systems, kits, and techniques are described for testing surfaces for the presence of hazardous contaminants, while minimizing user exposure to these contaminants. Even trace amounts of contaminants can be detected. A collection kit provides a swab that is simple to use, easy to hold and grip, allows the user to swab large areas of a surface, and keeps the user's hands away from the surface being tested. The kit also provides open and closed fluid transfer mechanism to transfer the collected fluid to a detection device while minimizing user exposure to hazardous contaminants in the collected fluid. Contamination detection kits can rapidly collect and detect hazardous drugs, including trace amounts of antineoplastic agents, in healthcare settings at the site of contamination.

Abstract: Contamination detection systems, kits, and techniques are described for testing surfaces for the presence of hazardous contaminants, while minimizing user exposure to these contaminants. Even trace amounts of contaminants can be detected. A collection kit provides a swab that is simple to use, easy to hold and grip, allows the user to swab large areas of a surface, and keeps the user's hands away from the surface being tested. The kit also provides open and closed fluid transfer mechanism to transfer the collected fluid to a detection device while minimizing user exposure to hazardous contaminants in the collected fluid. Contamination detection kits can rapidly collect and detect hazardous drugs, including trace amounts of antineoplastic agents, in healthcare settings at the site of contamination.

Abstract: Aspects of the disclosure relate to augmented reality devices for generating a composite scene including a real-world test environment and an augmented reality overlay visually representing a test area of the environment. Some devices can include wearable displays for displaying an overlay to a user, and other devices can include projectors for illuminating the test environment with the overlay.

Abstract: Needle-guidance systems, components, and methods thereof are disclosed. A needle-guidance system can include a console, a needle magnetizer incorporated into the console, an RFID-tag reader incorporated into the console, and an ultrasound probe. The console can be configured to instantiate a needle-guidance process for guiding insertion of a magnetized needle into a blood vessel of a patient using a combination of ultrasound-imaging data, magnetic-field data, and RFID-tag information for the needle received by the console. The ultrasound probe can be configured to provide to the console electrical signals corresponding to both the ultrasound-imaging data and the magnetic-field data.

Abstract: Aspects of the disclosure relate to augmented reality devices for generating a composite scene including a real-world test environment and an augmented reality overlay visually representing a test area of the environment. Some devices can include wearable displays for displaying an overlay to a user, and other devices can include projectors for illuminating the test environment with the overlay.

Abstract: A drug delivery device (100), including a body (104, 116) having a reservoir (164, 176) disposed therein for containing a medicament and an injection needle (152) for penetrating the skin of a patient, the needle (152) providing a path for the medicament between the reservoir (164, 176) and the patient. The device (100) also includes a needle cover (114) for selectively covering the injection needle (152), an adhesive (264) for selectively adhering the device to the patient, a release liner (500) for selectively covering a patient side of the adhesive (264), and a connecting means (112, 520, 512, 508, 524) for connecting the needle cover (114) and the release liner (500) such that removal of one of the needle cover (114) and the release liner (500) from the device (100) removes the other one of the needle cover (114) and the release liner (500).